BridgeBio Pharma, Inc. (BBIO) Net Income by Year
BridgeBio Pharma, Inc. reported a net loss of $732.9M in fiscal year 2025. This represents a decrease of 34.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $702.0M net loss. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters BridgeBio Pharma, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
BBIO Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
BBIO Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More BridgeBio Pharma, Inc. financials
Frequently Asked Questions
What was BridgeBio Pharma, Inc.'s net income in fiscal year 2025?
BridgeBio Pharma, Inc. reported a net loss of $732.9M in fiscal year 2025.
How fast is BridgeBio Pharma, Inc.'s net income growing?
BridgeBio Pharma, Inc. (BBIO) net income fell by 34.9% year over year, from -$543.3M to -$732.9M in fiscal year 2025.
What is BridgeBio Pharma, Inc.'s net income over the last twelve months?
BridgeBio Pharma, Inc. (BBIO) reported a $702.0M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has BridgeBio Pharma, Inc.'s net income changed over the years?
Across the 9 fiscal years this page covers, BridgeBio Pharma, Inc. (BBIO) net income went from -$43.8M in fiscal year 2017 to -$732.9M in fiscal year 2025.
What was BridgeBio Pharma, Inc.'s net income in the most recent quarter?
BridgeBio Pharma, Inc. (BBIO) reported -$155.9M in net income in Q2 2026. This represents an increase of 15.2% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what BridgeBio Pharma, Inc. (BBIO) reported on that line in every period on record.